{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T10:47:58Z","timestamp":1794307678982,"version":"4.9.0"},"reference-count":99,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education Malaysia","doi-asserted-by":"publisher","award":["FRGS\/1\/2022\/SKK10\/USM\/01\/1"],"award-info":[{"award-number":["FRGS\/1\/2022\/SKK10\/USM\/01\/1"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Streptococcus pneumoniae (S. pneumoniae) is a bacterial species often associated with the occurrence of community-acquired pneumonia (CAP). CAP refers to a specific kind of pneumonia that occurs in individuals who acquire the infection outside of a healthcare setting. It represents the leading cause of both death and morbidity on a global scale. Moreover, the declaration of S. pneumoniae as one of the 12 leading pathogens was made by the World Health Organization (WHO) in 2017. Antibiotics like \u03b2-lactams, macrolides, and fluoroquinolones are the primary classes of antimicrobial medicines used for the treatment of S. pneumoniae infections. Nevertheless, the efficacy of these antibiotics is diminishing as a result of the establishment of resistance in S. pneumoniae against these antimicrobial agents. In 2019, the WHO declared that antibiotic resistance was among the top 10 hazards to worldwide health. It is believed that penicillin-binding protein genetic alteration causes \u03b2-lactam antibiotic resistance. Ribosomal target site alterations and active efflux pumps cause macrolide resistance. Numerous factors, including the accumulation of mutations, enhanced efflux mechanisms, and plasmid gene acquisition, cause fluoroquinolone resistance. Furthermore, despite the advancements in pneumococcal vaccinations and artificial intelligence (AI), it is not feasible for individuals to rely on them indefinitely. The ongoing development of AI for combating antimicrobial resistance necessitates more research and development efforts. A few strategies can be performed to curb this resistance issue, including providing educational initiatives and guidelines, conducting surveillance, and establishing new antibiotics targeting another part of the bacteria. Hence, understanding the resistance mechanism of S. pneumoniae may aid researchers in developing a more efficacious antibiotic in future endeavors.<\/jats:p>","DOI":"10.3390\/medicina59111927","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T12:44:03Z","timestamp":1698756243000},"page":"1927","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["A Review of the Resistance Mechanisms for \u03b2-Lactams, Macrolides and Fluoroquinolones among Streptococcus pneumoniae"],"prefix":"10.3390","volume":"59","author":[{"given":"Nurul Izzaty Najwa","family":"Zahari","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, Kubang Kerian 16150, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3249-6357","authenticated-orcid":false,"given":"Engku Nur Syafirah","family":"Engku Abd Rahman","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, Kubang Kerian 16150, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1779-9571","authenticated-orcid":false,"given":"Ahmad Adebayo","family":"Irekeola","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, Kubang Kerian 16150, Malaysia"},{"name":"Microbiology Unit, Department of Biological Sciences, College of Natural and Applied Sciences, Summit University Offa, Offa PMB 4412, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1504-1705","authenticated-orcid":false,"given":"Naveed","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, Kubang Kerian 16150, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6774-9847","authenticated-orcid":false,"given":"Ali A.","family":"Rabaan","sequence":"additional","affiliation":[{"name":"Molecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran 31311, Saudi Arabia"},{"name":"College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia"},{"name":"Department of Public Health and Nutrition, The University of Haripur, Haripur 22610, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1653-4117","authenticated-orcid":false,"given":"Jawaher","family":"Alotaibi","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh 11564, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayea A.","family":"Alqahtani","sequence":"additional","affiliation":[{"name":"Medical Laboratory Department, Erhadh Hospital, Dammam 32434, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Y.","family":"Halawi","sequence":"additional","affiliation":[{"name":"Cytogenetics Department, Dammam Regional Laboratory and Blood Bank, Dammam 31411, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Ateeq","family":"Alamri","sequence":"additional","affiliation":[{"name":"Blood Bank Department, Dammam Regional Laboratory and Blood Bank, Dammam 31411, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8733-1472","authenticated-orcid":false,"given":"Mohammed S.","family":"Almogbel","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Hail, Hail 4030, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal H.","family":"Alfaraj","sequence":"additional","affiliation":[{"name":"Pediatric Department, Abqaiq General Hospital, First Eastern Health Cluster, Abqaiq 33261, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah Al","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Infectious Disease Division, Department of Internal Medicine, Dammam Medical Complex, Dammam 32245, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manar","family":"Almaghaslah","sequence":"additional","affiliation":[{"name":"Infectious Disease Division, Department of Internal Medicine, Dammam Medical Complex, Dammam 32245, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4045-0810","authenticated-orcid":false,"given":"Mohammed","family":"Alissa","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Prince Sattam bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0034-7624","authenticated-orcid":false,"given":"Chan Yean","family":"Yean","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, Kubang Kerian 16150, Malaysia"},{"name":"Hospital Universiti Sains Malaysia, Universiti Sains Malaysia, Health Campus, Kubang Kerian 16150, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (WHO) (2022, September 26). Pneumonia. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/pneumonia."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.mcna.2018.12.008","article-title":"Community-Acquired Pneumonia and Hospital-Acquired Pneumonia","volume":"103","author":"Lanks","year":"2019","journal-title":"Med. Clin. N. Am."},{"key":"ref_3","first-page":"108","article-title":"Clinical and Economic Burden of Community-Acquired Pneumonia amongst Adults in the Asia-Pacific Region","volume":"38","author":"Song","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/17476348.2019.1562339","article-title":"The Burden of Community-Acquired Bacterial Pneumonia in the Era of Antibiotic Resistance","volume":"13","author":"Peyrani","year":"2019","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1474-4422(05)70288-X","article-title":"Clinical Features, Complications, and Outcome in Adults with Pneumococcal Meningitis: A Prospective Case Series","volume":"5","author":"Weisfelt","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMra052116","article-title":"Community-Acquired Bacterial Meningitis in Adults","volume":"354","author":"Tunkel","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41579-018-0001-8","article-title":"Streptococcus Pneumoniae: Transmission, Colonization and Invasion","volume":"16","author":"Weiser","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_8","unstructured":"Cill\u00f3niz, C., Garcia-Vidal, C., Ceccato, A., and Torres, A. (2018). Antimicrobial Resistance in the 21st Century, Springer International Publishing."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"105058","DOI":"10.1016\/j.micinf.2022.105058","article-title":"Therapeutic Potential of Kaempferol on Streptococcus Pneumoniae Infection","volume":"25","author":"Xu","year":"2023","journal-title":"Microbes Infect."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1097\/MJT.0000000000000551","article-title":"Antimicrobial Resistant Streptococcus Pneumoniae: Prevalence, Mechanisms, and Clinical Implications","volume":"24","author":"Cherazard","year":"2017","journal-title":"Am. J. Ther."},{"key":"ref_11","unstructured":"World Health Organization (WHO) (2014). Antimicrobial Resistance: Global Report on Surveillance 2014, Antimicrobial Resistance Global Surveillance Report, World Health Organization."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global Antibiotic Consumption 2000 to 2010: An Analysis of National Pharmaceutical Sales Data","volume":"14","author":"Gandra","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00063198-199703000-00013","article-title":"Antimicrobial Resistance: Implications for Managing Respiratory Failure","volume":"3","author":"Chenoweth","year":"1997","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1086\/514953","article-title":"Prevalence of Antimicrobial Resistance Among Respiratory Tract Isolates of Streptococcus Pneumoniae in North America: 1997 Results from the SENTRY Antimicrobial Surveillance Program","volume":"27","author":"Doern","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0732-8893(98)00108-4","article-title":"Epidemiologic Trends in Nosocomial and Community-Acquired Infections Due to Antibiotic-Resistant Gram-Positive Bacteria: The Role of Streptogramins and Other Newer Compounds","volume":"33","author":"Jones","year":"1999","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.4065\/75.11.1161","article-title":"Antimicrobial Resistance in Streptococcus Pneumoniae: Implications for Patients With Community-Acquired Pneumonia","volume":"75","author":"Chenoweth","year":"2000","journal-title":"Mayo Clin. Proc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1469-0691.2010.03182.x","article-title":"Changes in Antimicrobial Resistance, Serotypes and Genotypes in Streptococcus Pneumoniae over a 30-Year Period","volume":"16","author":"Ardanuy","year":"2010","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1055\/s-0029-1202939","article-title":"Streptococcus Pneumoniae: Does Antimicrobial Resistance Matter?","volume":"30","author":"Lynch","year":"2009","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/43.suppl_2.1","article-title":"A Review of the Comparative In-Vitro Activities of 12 Antimicrobial Agents, with a Focus on Five New \u2018Respiratory Quinolones\u2019","volume":"43","author":"Blondeau","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMcp1214869","article-title":"Community-Acquired Pneumonia","volume":"370","author":"Wunderink","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/thoraxjnl-2013-204282","article-title":"Risk Factors for Community-Acquired Pneumonia in Adults in Europe: A Literature Review","volume":"68","author":"Torres","year":"2013","journal-title":"Thorax"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MCP.0000000000000052","article-title":"Community-Acquired Pneumonia","volume":"20","author":"Remington","year":"2014","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/00325481.2015.1074030","article-title":"Community-Acquired Pneumonia: An Overview","volume":"127","author":"Mandell","year":"2015","journal-title":"Postgrad. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"223S","DOI":"10.1378\/chest.95.3_Supplement.223S","article-title":"Pulmonary Host Defenses: State of the Art","volume":"95","author":"Reynolds","year":"1989","journal-title":"Chest"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Subramanian, K., Henriques-Normark, B., and Normark, S. (2019). Emerging Concepts in the Pathogenesis of the Streptococcus Pneumoniae: From Nasopharyngeal Colonizer to Intracellular Pathogen. Cell. Microbiol., 21.","DOI":"10.1111\/cmi.13077"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/mi.2014.55","article-title":"Antibody Blocks Acquisition of Bacterial Colonization through Agglutination","volume":"8","author":"Roche","year":"2015","journal-title":"Mucosal Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Murphy, K., and Weaver, C. (2017). Janeway\u2019s Immunobiology-9th Edition, Garland Science.","DOI":"10.1007\/978-3-662-56004-4"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1378\/chest.06-2869","article-title":"Reducing the Toll of Inflammatory Lung Disease","volume":"131","author":"Chaudhuri","year":"2007","journal-title":"Chest"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"113741","DOI":"10.1016\/j.ejmech.2021.113741","article-title":"The Antibacterial Activity of Fluoroquinolone Derivatives: An Update (2018\u20132021)","volume":"224","author":"Jia","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"100971","DOI":"10.1016\/j.disamonth.2020.100971","article-title":"Antimicrobial Resistance, Mechanisms and Its Clinical Significance","volume":"66","author":"Abushaheen","year":"2020","journal-title":"Disease-a-Month"},{"key":"ref_31","first-page":"26","article-title":"Fluoroquinolone Antibiotics: An Overview","volume":"2","author":"Brar","year":"2020","journal-title":"Adesh Univ. J. Med. Sci. Res."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Rabaan, A.A., Alhumaid, S., Al Mutair, A., Garout, M., Abulhamayel, Y., Halwani, M.A., Alestad, J.H., Al Bshabshe, A., Sulaiman, T., and AlFonaisan, M.K. (2022). Application of Artificial Intelligence in Combating High Antimicrobial Resistance Rates. Antibiotics, 11.","DOI":"10.3390\/antibiotics11060784"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Rabaan, A.A., Eljaaly, K., Alhumaid, S., Albayat, H., Al-Adsani, W., Sabour, A.A., Alshiekheid, M.A., Al-Jishi, J.M., Khamis, F., and Alwarthan, S. (2022). An Overview on Phenotypic and Genotypic Characterisation of Carbapenem-Resistant Enterobacterales. Medicina, 58.","DOI":"10.3390\/medicina58111675"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S2213-2600(18)30271-6","article-title":"Superbugs: An Arms Race Against Bacteria","volume":"6","author":"Burki","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.tibs.2018.06.011","article-title":"How Macrolide Antibiotics Work","volume":"43","author":"Mankin","year":"2018","journal-title":"Trends Biochem. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e02487-19","DOI":"10.1128\/AAC.02487-19","article-title":"A Roadblock-and-Kill Mechanism of Action Model for the DNA-Targeting Antibiotic Ciprofloxacin","volume":"64","author":"Ojkic","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Li, L., Ma, J., Yu, Z., Li, M., Zhang, W., and Sun, H. (2023). Epidemiological Characteristics and Antibiotic Resistance Mechanisms of Streptococcus Pneumoniae: An Updated Review. Microbiol. Res., 266.","DOI":"10.1016\/j.micres.2022.127221"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"338","DOI":"10.12688\/f1000research.22341.1","article-title":"Recent Advances in the Epidemiology and Prevention of Streptococcus Pneumoniae Infections","volume":"9","author":"Feldman","year":"2020","journal-title":"F1000Research"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1111\/apa.15795","article-title":"Multi-drug Resistance in Streptococcus Pneumoniae among Children in Rural Vietnam More than Doubled from 1999 to 2014","volume":"110","author":"Larsson","year":"2021","journal-title":"Acta Paediatr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jinf.2019.07.004","article-title":"International Prevalence and Risk Factors Evaluation for Drug-Resistant Streptococcus Pneumoniae Pneumonia","volume":"79","author":"Aliberti","year":"2019","journal-title":"J. Infect."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1086\/340400","article-title":"Resistance among Streptococcus Pneumoniae: Implications for Drug Selection","volume":"34","author":"Appelbaum","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"ref_42","first-page":"830","article-title":"Mutation in Ompk35 Are Evolution Pathway in Antibiotic Resistance","volume":"23","author":"Jaber","year":"2022","journal-title":"HIV Nurs."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1126\/science.aaf9621","article-title":"A General Catalytic \u03b2-C\u2013H Carbonylation of Aliphatic Amines to \u03b2-Lactams","volume":"354","author":"Willcox","year":"2016","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.arcmed.2020.06.004","article-title":"Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to Be Beneficial as an Adjunct Treatment in COVID-19?","volume":"51","author":"Karampela","year":"2020","journal-title":"Arch. Med. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1099\/jmm.0.000801","article-title":"In Vitro Activity of \u03b2-Lactams in Combination with Avibactam against Multidrug-Resistant Pseudomonas Aeruginosa, Stenotrophomonas Maltophilia and Achromobacter Xylosoxidans Isolates from Patients with Cystic Fibrosis","volume":"67","author":"Mathy","year":"2018","journal-title":"J. Med. Microbiol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/jac\/dky423","article-title":"In Vitro Activity of Seven \u03b2-Lactams Including Ceftolozane\/Tazobactam and Ceftazidime\/Avibactam against Burkholderia Cepacia Complex, Burkholderia Gladioli and Other Non-Fermentative Gram-Negative Bacilli Isolated from Cystic Fibrosis Patients","volume":"74","author":"Massip","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0140-6736(67)92346-X","article-title":"A Resistant Pneumococcus","volume":"2","author":"Hansman","year":"1967","journal-title":"Lancet"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1086\/598975","article-title":"Rationale for Revised Penicillin Susceptibility Breakpoints versus Streptococcus Pneumoniae: Coping with Antimicrobial Susceptibility in an Era of Resistance","volume":"48","author":"Weinstein","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ijmm.2007.02.009","article-title":"Crossing the Barrier: Evolution and Spread of a Major Class of Mosaic Pbp2x in Streptococcus Pneumoniae, S. Mitis and S. Oralis","volume":"297","author":"Chi","year":"2007","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2217\/fmb.12.2","article-title":"Molecular Mechanisms of \u03b2-Lactam Resistance in Streptococcus Pneumoniae","volume":"7","author":"Hakenbeck","year":"2012","journal-title":"Future Microbiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1128\/AAC.00429-15","article-title":"Commensal Streptococci Serve as a Reservoir for \u03b2-Lactam Resistance Genes in Streptococcus Pneumoniae","volume":"59","author":"Jensen","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1086\/516532","article-title":"A Global Gene Pool for High-Level Cephalosporin Resistance in Commensal Streptococcus Species and Streptococcus Pneumoniae","volume":"176","author":"Reichmann","year":"1997","journal-title":"J. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1128\/JB.182.23.6798-6805.2000","article-title":"Distribution of the Mosaic Structured MurM Genes among Natural Populations of Streptococcus Pneumoniae","volume":"182","author":"Filipe","year":"2000","journal-title":"J. Bacteriol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/10766290152773310","article-title":"The Role of MurMN Operon in Penicillin Resistance and Antibiotic Tolerance of Streptococcus Pneumoniae","volume":"7","author":"Filipe","year":"2001","journal-title":"Microb. Drug Resist."},{"key":"ref_55","first-page":"77","article-title":"Extended-Spectrum Resistance to \u03b2-Lactams\/\u03b2-Lactamase Inhibitors (ESRI) Evolved from Low-Level Resistant Escherichia Coli","volume":"75","author":"Bonnin","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1128\/AAC.00234-06","article-title":"Macrolide and Azithromycin Use Are Linked to Increased Macrolide Resistance in Streptococcus Pneumoniae","volume":"50","author":"Bergman","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":"Effect of Azithromycin and Clarithromycin Therapy on Pharyngeal Carriage of Macrolide-Resistant Streptococci in Healthy Volunteers: A Randomised, Double-Blind, Placebo-Controlled Study","volume":"369","author":"Lammens","year":"2007","journal-title":"Lancet"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"102095","DOI":"10.1016\/j.pupt.2021.102095","article-title":"The Immunomodulatory Effects of Macrolide Antibiotics in Respiratory Disease","volume":"71","author":"Pollock","year":"2021","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2174\/1568026033452159","article-title":"Macrolide Antibiotics: Binding Site, Mechanism of Action, Resistance","volume":"3","author":"Gaynor","year":"2003","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_60","unstructured":"Patel, P.H., and Hashmi, M.F. (2022). Macrolides, StatPearls Publishing."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e24427","DOI":"10.1002\/jcla.24427","article-title":"Mechanism of Action, Resistance, Synergism, and Clinical Implications of Azithromycin","volume":"36","author":"Heidary","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Schroeder, M.R., and Stephens, D.S. (2016). Macrolide Resistance in Streptococcus Pneumoniae. Front. Cell. Infect. Microbiol., 6.","DOI":"10.3389\/fcimb.2016.00098"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/313452","article-title":"Prevalence of Macrolide Resistance Mechanisms in Streptococcus Pneumoniae Isolates from a Multicenter Antibiotic Resistance Surveillance Study Conducted in the United States in 1994\u20131995","volume":"29","author":"Shortridge","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1128\/AAC.00060-11","article-title":"Induction of Efflux-Mediated Macrolide Resistance in Streptococcus Pneumoniae","volume":"55","author":"Chancey","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"He, W., Jiang, K., Qiu, H., Liao, L., and Wang, S. (2022). 16-Membered Ring Macrolides and Erythromycin Induce ErmB Expression by Different Mechanisms. BMC Microbiol., 22.","DOI":"10.1186\/s12866-022-02565-3"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Wang, S., Jiang, K., Du, X., Lu, Y., Liao, L., He, Z., and He, W. (2021). Translational Attenuation Mechanism of ErmB Induction by Erythromycin Is Dependent on Two Leader Peptides. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.690744"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1038\/ncomms4501","article-title":"Molecular Basis for Erythromycin-Dependent Ribosome Stalling during Translation of the ErmBL Leader Peptide","volume":"5","author":"Arenz","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1128\/AAC.01376-07","article-title":"Translational Attenuation and MRNA Stabilization as Mechanisms of Erm (B) Induction by Erythromycin","volume":"52","author":"Min","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nchembio.1998","article-title":"Nascent Peptide Assists the Ribosome in Recognizing Chemically Distinct Small Molecules","volume":"12","author":"Gupta","year":"2016","journal-title":"Nat. Chem. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4103\/ijmr.IJMR_2079_17","article-title":"Efflux Pump Inhibitors for Bacterial Pathogens: From Bench to Bedside","volume":"149","author":"Sharma","year":"2019","journal-title":"Indian J. Med. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2217\/fmb.12.63","article-title":"Acquired Inducible Antimicrobial Resistance in Gram-Positive Bacteria","volume":"7","author":"Chancey","year":"2012","journal-title":"Future Microbiol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Chancey, S.T., Bai, X., Kumar, N., Drabek, E.F., Daugherty, S.C., Colon, T., Ott, S., Sengamalay, N., Sadzewicz, L., and Tallon, L.J. (2015). Transcriptional Attenuation Controls Macrolide Inducible Efflux and Resistance in Streptococcus Pneumoniae and in Other Gram-Positive Bacteria Containing Mef\/Mel(Msr(D)) Elements. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116254"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1128\/AAC.49.10.4203-4209.2005","article-title":"Macrolide Efflux in Streptococcus Pneumoniae Is Mediated by a Dual Efflux Pump (Mel and Mef) and Is Erythromycin Inducible","volume":"49","author":"Ambrose","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1128\/AAC.01756-09","article-title":"Human Antimicrobial Peptide LL-37 Induces MefE\/Mel-Mediated Macrolide Resistance in Streptococcus Pneumoniae","volume":"54","author":"Zhou","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1800141","DOI":"10.1002\/ardp.201800141","article-title":"Recent Updates of Fluoroquinolones as Antibacterial Agents","volume":"351","author":"Ezelarab","year":"2018","journal-title":"Arch. Pharm."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/ijmr.IJMR_755_18","article-title":"Next-Generation Strategy for Treating Drug Resistant Bacteria: Antibiotic Hybrids","volume":"149","author":"Gupta","year":"2019","journal-title":"Indian J. Med. Res."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Khondker, A., Bider, R.-C., Passos-Gastaldo, I., Wright, G.D., and Rheinst\u00e4dter, M.C. (2021). Membrane Interactions of Non-Membrane Targeting Antibiotics: The Case of Aminoglycosides, Macrolides, and Fluoroquinolones. Biochim. Biophys. Acta-Biomembr., 1863.","DOI":"10.1016\/j.bbamem.2020.183448"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"100296","DOI":"10.1016\/j.mtchem.2020.100296","article-title":"Insights on Fluoroquinolones in Cancer Therapy: Chemistry and Recent Developments","volume":"17","author":"Sharma","year":"2020","journal-title":"Mater. Today Chem."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Ferreira, M., and Gameiro, P. (2021). Fluoroquinolone-Transition Metal Complexes: A Strategy to Overcome Bacterial Resistance. Microorganisms, 9.","DOI":"10.3390\/microorganisms9071506"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.survophthal.2004.01.005","article-title":"Fluoroquinolones: Mechanism of Action, Classification, and Development of Resistance","volume":"49","author":"Blondeau","year":"2004","journal-title":"Surv. Ophthalmol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejmech.2018.11.032","article-title":"Fluoroquinolone-Isatin Hybrids and Their Biological Activities","volume":"162","author":"Xu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3345\/kjp.2013.56.5.196","article-title":"Systemic Use of Fluoroquinolone in Children","volume":"56","author":"Choi","year":"2013","journal-title":"Korean J. Pediatr."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e1034","DOI":"10.1542\/peds.2011-1496","article-title":"The Use of Systemic and Topical Fluoroquinolones","volume":"128","author":"Bradley","year":"2011","journal-title":"Pediatrics"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijantimicag.2010.04.013","article-title":"Evolving Trends in Streptococcus Pneumoniae Resistance: Implications for Therapy of Community-Acquired Bacterial Pneumonia","volume":"36","author":"Jones","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"a025320","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.micinf.2012.01.012","article-title":"Streptococcus Pneumoniae: The Evolution of Antimicrobial Resistance to Beta-Lactams, Fluoroquinolones and Macrolides","volume":"14","author":"Cornick","year":"2012","journal-title":"Microbes Infect."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/jac\/dkf047","article-title":"Dual Activity of Fluoroquinolones against Streptococcus Pneumoniae: The Facts behind the Claims","volume":"49","author":"Smith","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_88","unstructured":"Hooper, D.C. (2022, November 29). Emerging Mechanisms of Fluoroquinolone Resistance. Available online: https:\/\/www.medscape.com\/viewarticle\/414418_3."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JCM.01260-20","article-title":"Applications of Machine Learning to the Problem of Antimicrobial Resistance: An Emerging Model for Translational Research","volume":"59","author":"Anahtar","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"113922","DOI":"10.1016\/j.addr.2021.113922","article-title":"Artificial Intelligence and Machine Learning Assisted Drug Delivery for Effective Treatment of Infectious Diseases","volume":"178","author":"He","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bsheal.2020.08.003","article-title":"A Review of Artificial Intelligence Applications for Antimicrobial Resistance","volume":"3","author":"Lv","year":"2021","journal-title":"Biosaf. Health"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00294-021-01156-5","article-title":"The Role of Artificial Intelligence in the Battle against Antimicrobial-Resistant Bacteria","volume":"67","author":"Lau","year":"2021","journal-title":"Curr. Genet."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-981-19-6379-7_12","article-title":"Role of Nature-Inspired Intelligence in Genomic Diagnosis of Antimicrobial Resistance","volume":"1066","author":"Sharma","year":"2023","journal-title":"Stud. Comput. Intell."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13756-021-00931-w","article-title":"Surveillance of Antimicrobial Resistance in Low- and Middle-Income Countries: A Scattered Picture","volume":"10","author":"Iskandar","year":"2021","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1016\/j.vaccine.2021.02.063","article-title":"Dynamics of Antimicrobial Resistance of Streptococcus Pneumoniae Following PCV10 Introduction in Brazil: Nationwide Surveillance from 2007 to 2019","volume":"39","author":"Brandileone","year":"2021","journal-title":"Vaccine"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"de Kraker, M.E.A., Stewardson, A.J., and Harbarth, S. (2016). Will 10 Million People Die a Year Due to Antimicrobial Resistance by 2050?. PLoS Med., 13.","DOI":"10.1371\/journal.pmed.1002184"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/s41467-019-09658-0","article-title":"Visualizing Conformation Transitions of the Lipid II Flippase MurJ","volume":"10","author":"Kuk","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1021\/acs.chemrev.1c00773","article-title":"The Bacterial Cell Wall: From Lipid II Flipping to Polymerization","volume":"122","author":"Kumar","year":"2022","journal-title":"Chem. Rev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.1254522","article-title":"MurJ Is the Flippase of Lipid-Linked Precursors for Peptidoglycan Biogenesis","volume":"345","author":"Sham","year":"2014","journal-title":"Science"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/11\/1927\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:14:41Z","timestamp":1760130881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/59\/11\/1927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":99,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["medicina59111927"],"URL":"https:\/\/doi.org\/10.3390\/medicina59111927","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]}}}